Table: Sapporo Clinical Lab -2015/16 group results

Sapporo Clinical Laboratory

13/05/2016 07:30

May 13 (Reuters)-  
          Sapporo Clinical Laboratory Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2016    Mar 31, 2015   Mar 31, 2017     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           17.53           17.17          17.69         8.69     
               (+2.1 pct)      (+3.7 pct)     (+0.9 pct)    (+1.1 pct)  
  Operating      974 mln         869 mln        697 mln      364 mln    
               (+12.0 pct)     (-4.0 pct)     (-28.4 pct)  (-27.3 pct)  
  Recurring      999 mln         896 mln        727 mln      379 mln    
               (+11.5 pct)     (-3.9 pct)     (-27.3 pct)  (-25.8 pct)  
  Net 
  Net            590 mln         573 mln        476 mln      249 mln    
               (+3.0 pct)      (+16.1 pct)    (-19.4 pct)  (-22.2 pct)  
  EPS          169.72 yen      150.97 yen     136.85 yen    71.59 yen   
  Ann Div 
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div       11.00 yen       12.00 yen      11.00 yen                
   
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T 
  ((Tokyo Headline News Desk +813 6441 1812))